HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tschabitscher, D. Articles by Lind, P. Search for Related Content PubMed PubMed Citation Articles by Tschabitscher, D. Articles by Lind, P.

Technetium-99m-Tetrofosmin Uptake in Sarcoidosis Stage I

Departments of Nuclear Medicine and Special Endocrinology and Institute of Pathology, Landeskrankenhaus Klagenfurt, Institute of Nuclear Medicine, Krankenanstalt Rudolfstiftung, Vienna, Austria

Correspondence: For correspondence or reprints contact: Peter Lind, MD, Department of Nuclear Medicine and Special Endocrinology, St. Veiterstraße 47, A-9020 Klagenfurt, Austria.

ABSTRACT

The uptake of ^99mTc-tetrofosmin in enlarged lymph nodes, of the lung hilus, in the case of sarcoidosis Stage I (histopathologically confirmed by mediastinoscopic biopsy) is demonstrated. On a routine chest radiograph of a 78-yr-old woman, hilar lymphadenopathy was first detected. In the following mammography, disseminated micro calcilications were found in the left breast and a ^99mTc-tetrofosmin study was performed for detection of breast cancer. Scintigraphy using ^99mTc-tetrofosmin showed clear uptake in the hilar lymph nodes, but not in the left breast The ^99mTc-tetrofosmin uptake in the hilar lymph nodes was due to sarcoidosis confirmed by histology. Therefore, ^99mTc-tetrofosmin scintigraphy may be useful in patients with suspected sarcoidosis, especially in Stage I.

Key Words: technetium-99m-tetrofosmin • hilar lymphadenopathy • sarcoidosis Stage I • SPECT